For more information, visit ArkansasEDC.com
GLP-1RAS AND DIABETIC RETINOPATHY The phenomenon of worsening diabetic retinopathy (DR), often termed rebound retinopathy, is a well-established, paradoxical retinal finding linked to improved blood glucose levels, typically observed 3 months to 3 years after intense glucose lowering
Questions to ask your care team If you are considering a GLP-1 medication, these questions can help guide a conversation with your care team: Is a GLP-1 medication appropriate for my situation
This can occur because Semaglutide affects the digestive system, slowing down how quickly food moves through your stomach
Recording concentration alongside reconstitution date and water volume makes future dose checks much easier to audit
Overview of Clinical Trials on Tirzepatide Before a medication like tirzepatide is approved for use, it goes through multiple phases of clinical trials